JP Stock MarketDetailed Quotes

7074 Twenty-four seven

Watchlist
  • 347
  • +9+2.66%
20min DelayNot Open Jan 22 15:30 JST
2.94BMarket Cap-3.38P/E (Static)

Twenty-four seven Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Twenty-four seven Q4 2024 Earnings Date

Currency：JPYJan 15, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
582.00M
--
-18.60%
EPS
--
0.34
--
+101.48%
Analyst Rating
No Data

Twenty-four seven Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 15, 20242024/Q3650.000M / ----
Apr 15, 20242024/Q1619.000M / ----
Oct 13, 20232023/Q3801.000M / ----
Apr 14, 20232023/Q1824.000M / ----
Oct 14, 20222022/Q31.076B / ----
DatePeriodRevenue/EstimateEarnings Call
Oct 15, 20242024/Q3650.000M / ----
Apr 15, 20242024/Q1619.000M / ----
Oct 13, 20232023/Q3801.000M / ----
Apr 14, 20232023/Q1824.000M / ----
Oct 14, 20222022/Q31.076B / ----

Unlock Free Earnings Estimates

Twenty-four seven Earnings Reports

  • Twenty-four seven: Supplementary explanation of financial results for the fiscal year ending 2024/11

    Jan 15 02:00 ET

  • Twenty-four seven: Summary of financial results for the fiscal year ending 2024/11 [Japanese GAAP] (unconsolidated)

    Jan 15 02:00 ET

  • Twenty-four seven: Extraordinary Report

    Nov 28, 2024 01:30 ET

  • Twenty-four seven: Extraordinary Report

    Oct 16, 2024 02:50 ET

    • Read more

    Top JP Stock Gainers
    Symbol Price % Chg
    Palemo Holdings
    2778
    160 +28.00%
    Spancrete
    5277
    268 +22.37%
    Renascience
    4889
    854 +21.31%
    Oncolys BioPharma
    4588
    608 +19.69%
    Kitagawa Seiki
    6327
    646 +18.32%

    See the daily top gainer.